Unique Product Processing & Safety

Carmell’s production process utilizes allogenic pooled plasma that has been screened and processed by an FDA registered and AABB (American Association of Blood Banks) accredited U.S. blood bank and is therefore considered free of known blood-borne pathogens. We then rescreen the pooled plasma as a safety precaution using sensitive nucleic acid amplification technology (NAT), and use the steps of pasteurization and irradiation to remove any new viral contaminants that conventional screening may miss.

Our patented manufacturing process allows us to fine-tune the degradation of the final product and control the release of regenerative factors. The final product is additional terminally sterilized after packaging, meeting FDA’s and EMA’s stringent requirements to ensure safety.